Heart risks in rheumatoid arthritis patients
Part of Bones, joints & muscles, Immune system & allergy, Skin clinical trials.
This trial looks at cardiovascular risk factors in people with rheumatoid arthritis (RA), comparing those who test positive or negative for certain blood markers. It aims to understand how heart health may differ between these groups.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older.
- You have been diagnosed with rheumatoid arthritis for at least six months.
- Your diagnosis was confirmed using standard medical criteria (ACR/EULAR 2010).
- You do not have other autoimmune diseases like lupus or scleroderma.
- You are not taking medications that strongly affect heart health, except those used for standard RA treatment.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses a special heart CT scan to look for early signs of heart disease in people with rheumatoid arthritis. It may help find problems before symptoms start.
This study looks at specific genetic differences and blood levels of immune proteins to see how they relate to rheumatoid arthritis risk and how active the disease is. It may help researchers understand who is more likely to have rheumatoid arthritis and when the condition is more active.
This study compares two treatment approaches for people with active rheumatoid arthritis who also have heart disease risk factors. It tests whether a newer drug called tofacitinib, combined with cholesterol medication, can better protect the heart than traditional TNF-inhibitor treatments.
This trial is for people with rheumatoid arthritis (RA) who are at risk for developing interstitial lung disease, which is scarring in the lungs. It aims to better understand why this happens and how to help prevent or manage it.
This study looks at people with early arthritis related to rheumatoid arthritis, psoriatic arthritis, or psoriasis. Researchers want to understand how these early conditions behave and may help guide better treatment decisions.
This study is looking at early rheumatoid arthritis (RA) and heart health. It compares people newly diagnosed with RA (within the last 6 months) to healthy people of similar age and sex. The goal is to see if there are early signs of hardening of the arteries in people with RA.
Hear when a new Rheumatoid arthritis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.